Regadenoson is an A2A adenosine receptor agonist that is a coronary vasodilator that is commonly used in pharmacologic stress testing. It produces hyperemia quickly and maintains it for a duration that is useful for radionuclide myocardial perfusion imaging. The selective nature of the drug makes it preferable to other stress agents such as adenosine, which are less selective and therefore cause more side-effects.
Gao, Xihui; Qian, Jun; Zheng, Shuyan; Changyi, Yinzhi; Zhang, Jianping; Ju, Shenghong; Zhu, Jianhua; Li, Cong. Overcoming the Blood-Brain Barrier for Delivering Drugs into the Brain by Using Adenosine Receptor Nanoagonist. ACS Nano. Volume 8. Issue 4. Pages 3678-3689. 2014.
Zablocki, Jeff; Elzein, Elfatih. Process for preparing an A2a-adenosine receptor agonist and its polymorphs. Assignee Cv Therapeutics, Inc., USA. WO 2008143667. (2008).
Kovi, Ravishanker; Kannapan, Jayaraman; Thirunavakarasu, Ananda Babu; Fadadu, Piyush D.; Thumar, Piyush B. Novel polymorph of regadenoson and process for preparation thereof. Assignee Apicore US LLC, USA. US 20180127452. (2018).
Rangisetty, Jagadeesh Babu; Pullagurla, Manik Reddy; Nandakumar, Mecheril Valsan; Naidu, Dokula Neelam. Process for the preparation of a novel polymorph of regadenoson. Assignee Biophore India Pharmaceuticals Pvt. Ltd., India. IN 2013CH02262. (2014).
Grisenti, Paride; Shahrzad Reza, Elahi; Guazzi, Giuseppe; Argese, Maria. Stable solid forms of regadenoson. Assignee Euticals S.p.A., Italy. EP 2789624. (2014).
Pullagurla, Manik Reddy; Rangisetty, Jagadeesh Babu; Nandakumar, Mecheril Valsan. Novel process for the preparation of (1-{9-[(4s,2r,3r,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-aminopurin-2-yl}pyrazole-4-yl)-n-methylcarboxamide. Assignee Biophore India Pharmaceuticals Pvt. Ltd., India. IN 2012CH04486. (2016).
Liu, Wei; Zhang, Zhigang; Ren, Zhen. Process for preparation of Regadenoson. Assignee Shanghai Ziyuan Pharmaceutical Co., Ltd., Peop. Rep. China. CN 104744540. (2015).
Zhang, Xiaoheng; Mei, Lijun. A process for the preparation of regadenoson. Assignee ScinoPharm Taiwan, Ltd., Peop. Rep. China; ScinoPharm Singapore Pte, Ltd. WO 2015085497. (2015).
Chai, Jian; Luo, Hairong; Gu, Rongling; Zeng, Shuping; Li, Jiang; Ma, Jing. Novel regadenoson intermediates, their preparation method and application. Assignee Zhejiang Hisun Pharmaceutical Co., Ltd., Peop. Rep. China. CN 104513241. (2015).
Luo, Hairong; Chai, Jian; Gu, Rongling; Yu, Xufeng. Synthesis of regadenoson. Zhongguo Yiyao Gongye Zazhi. Volume 45. Issue 8. Pages 705-707. 2014.
